Latest Insider Transactions at Spectrum Pharmaceuticals Inc (SPPI)
This section provides a real-time view of insider transactions for Spectrum Pharmaceuticals Inc (SPPI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SPECTRUM PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SPECTRUM PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2021
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,672
-1.05%
|
$14,016
$3.64 P/Share
|
|
Feb 19
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
3,295
-0.93%
|
$9,885
$3.64 P/Share
|
|
Feb 19
2021
|
Joseph W. Turgeon CEO & President |
SELL
Open market or private sale
|
Direct |
7,257
-1.12%
|
$21,771
$3.64 P/Share
|
|
Feb 18
2021
|
Francois Lebel Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,309
+20.86%
|
-
|
|
Feb 18
2021
|
Thomas J Riga Director |
BUY
Grant, award, or other acquisition
|
Direct |
134,410
+22.44%
|
-
|
|
Feb 18
2021
|
Kurt A Gustafson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
119,579
+21.15%
|
-
|
|
Feb 18
2021
|
Keith M Mc Gahan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,309
+23.72%
|
-
|
|
Feb 18
2021
|
Joseph W. Turgeon CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
278,090
+30.02%
|
-
|
|
Feb 17
2021
|
Jeff L Vacirca Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+7.35%
|
$30,000
$3.61 P/Share
|
|
Feb 10
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
2,500
-1.01%
|
$7,500
$3.93 P/Share
|
|
Feb 09
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
1,977
-0.79%
|
$5,931
$3.93 P/Share
|
|
Jan 20
2021
|
Joseph W. Turgeon CEO & President |
SELL
Open market or private sale
|
Direct |
3,889
-1.04%
|
$15,556
$4.31 P/Share
|
|
Jan 20
2021
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,944
-0.58%
|
$7,776
$4.31 P/Share
|
|
Jan 20
2021
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.94%
|
$40,000
$4.31 P/Share
|
|
Jan 19
2021
|
Joseph W. Turgeon CEO & President |
SELL
Open market or private sale
|
Direct |
3,844
-1.02%
|
$11,532
$3.81 P/Share
|
|
Jan 19
2021
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,582
-0.77%
|
$7,746
$3.81 P/Share
|
|
Jan 19
2021
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
76,283
-9.41%
|
$228,849
$3.91 P/Share
|
|
Dec 24
2020
|
Jeff L Vacirca Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+7.94%
|
$30,000
$3.79 P/Share
|
|
Dec 16
2020
|
Joseph W. Turgeon CEO & President |
SELL
Open market or private sale
|
Direct |
150,899
-28.54%
|
$603,596
$4.7 P/Share
|
|
Dec 14
2020
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,696
-7.12%
|
$128,480
$5.0 P/Share
|
|
Dec 10
2020
|
Nora Brennan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Nov 18
2020
|
Joseph W. Turgeon CEO & President |
SELL
Open market or private sale
|
Direct |
162,473
-23.51%
|
$649,892
$4.13 P/Share
|
|
Nov 09
2020
|
Jeff L Vacirca Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+8.62%
|
$30,000
$3.78 P/Share
|
|
Nov 09
2020
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$15,000
$3.56 P/Share
|
|
Nov 06
2020
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,025
-2.28%
|
$21,075
$3.5 P/Share
|